(Attachment)
Designation of “Shitei Yakubutsu” (designated substances) based on the Act on
Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and
Medical Devices (1960, Law No.145)
In order to prevent the abuse of substances with probable effects on the central
nervous system and clarify the regulation under the Act on Securing Quality, Efficacy
and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter
referred to as the “Act”), the Minister of Health, Labour and Welfare of Japan proposes
to designate the following substances as “Shitei Yakubutsu” (designated substances).
Manufacture, import, sale, simple ownership and the use of “designated substances” are
banned except for the “proper uses” (see below).
●The proposed substances as “Shitei Yakubutsu”
*Abbreviation is put in parentheses.
1. [1-(Cyclohexylmethyl)-1 H-indol-3-yl] （naphthalen-1-yl ）
methanone
(NE-CHMIMO 、JWH-018 cyclohexylmethyl derivative )
2. 1-(Benzofuran- ４-yl)-N-ethylpropan-2-amine
(4-EAPB )
3.1-(Benzofuran-6-yl)- N-ethylpropan-2-amine
(6-EAPB )
●The proposed “proper uses” for the above “Shitei Yakubutsu”
1. To be used for researches or tests at the government, the local governments,
agencies thereof, technical colleges, inter-university research institutes, the
independent administrative agencies and the local independent administrative
agencies
2. To be used for tests under the Act, and
3. To be used for forensic use